Melanotan I (MT-I) 10MG

Melanotan I (MT-I), chemically known as α-MSH (alpha-melanocyte-stimulating hormone), is a synthetic peptide derived from the natural hormone produced by the pituitary gland. This peptide is a key component in the study of skin pigmentation, hormonal regulation, and its potential effects on mood, energy levels, and melanocortin receptor activity. As a research-use-only compound, MT-I is intended for academic and scientific investigations only, not for therapeutic or cosmetic applications.

Research Context

Melanotan I has been extensively researched for its role in stimulating melanin production, which influences skin pigmentation and sun protection. The peptide binds to melanocortin-1 receptors (MC1R) in melanocytes, triggering the synthesis of melanin in response to ultraviolet (UV) exposure. Early studies explored its use in dermatological research, including investigations into tanning mechanisms, skin cancer prevention, and potential psychological effects. However, due to its ability to induce severe skin reactions (e.g., erythema and hyperpigmentation), clinical applications have been limited in humans.

Research Overview

MT-I remains a valuable tool in pharmacological and biological research, particularly for examining:

• Melanocortin receptor mechanisms
• Skin pigmentation and UV-induced tanning responses
• Behavioral and physiological effects under controlled conditions
• Potential interactions with other endogenous peptides and signaling pathways

Its structural similarities to endogenous hormones like α-MSH also make it useful in studies of hormone receptor binding and downstream signaling cascades.

Key Research Focus Areas

• Skin Pigmentation and Melanin Production:
  MT-I is primarily studied for its capacity to induce melanin synthesis in melanocytes, making it a valuable model for investigating sun protection mechanisms and pigmentary disorders.
• Pharmacodynamics of MC1R Activation:
  Research explores how MT-I and related peptides modulate receptor signaling, which could inform the development of targeted therapeutic agents for conditions like vitiligo or melanoma.
• Psychological and Behavioral Effects:
  Early anecdotal reports suggested MT-I may influence mood or energy levels, prompting studies to dissect its role in endocrine and neuroendocrine regulation under experimental conditions.
• Toxicology and Safety Profiles:
  Investigations into MT-I’s acute and chronic effects on skin integrity, immune responses, and potential carcinogenic risks are critical for its safe use in research settings.

Caution: MT-I should only be handled by trained professionals in a research environment with appropriate safety protocols. This product is not intended for human or animal consumption and is for academic, industrial, or pharmaceutical development use only.

For Research Use Only. Not for Human or Animal Consumption.

Distribution and use of this compound are governed by applicable research regulations. Adherence to local laws and institutional guidelines is mandatory. Unauthorized distribution or possession may be illegal.